top of page

מן העיתונות
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to...

NEXALIN
1 בנוב׳ 2024זמן קריאה 2 דקות
Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease
New Data Confirms DIFS Improves Cognitive Function and Restores Brain Activity in Alzheimer’s Patients HOUSTON, TX, Oct. 28, 2024 (GLOBE...

NEXALIN
28 באוק׳ 2024זמן קריאה 5 דקות
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from...

NEXALIN
22 באוק׳ 2024זמן קריאה 4 דקות

NEXALIN
20 באוק׳ 2024זמן קריאה 0 דקות
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients
Groundbreaking Trial Reveals DIFS Increases Neural Activity and Blood Flow in the Hippocampus, Offering Hope for Alzheimer’s Treatment...

NEXALIN
17 באוק׳ 2024זמן קריאה 4 דקות
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency...

NEXALIN
14 באוק׳ 2024זמן קריאה 4 דקות
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment
Meeting showcases the potential role of Nexalin’s neurostimulation technology in revolutionizing opioid treatment through virtual care...

NEXALIN
5 בספט׳ 2024זמן קריאה 3 דקות

NEXALIN
29 ביולי 2024זמן קריאה 0 דקות
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting...

NEXALIN
18 ביולי 2024זמן קריאה 4 דקות
Nexalin Technology Announces Closing of $5.2 Million Public Offering
HOUSTON, TX, July 01, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced...

NEXALIN
1 ביולי 2024זמן קריאה 3 דקות
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
HOUSTON, TX, June 27, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced...

NEXALIN
27 ביוני 2024זמן קריאה 3 דקות
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
Study demonstrates strong statistical separation between patients receiving Nexalin’s DIFS® technology in combination with escitalopram...

NEXALIN
26 ביוני 2024זמן קריאה 4 דקות
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today...

NEXALIN
20 ביוני 2024זמן קריאה 3 דקות
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
Brazil represents the 9th largest economy in the world with more than 35 million afflicted by mental health disorders HOUSTON, TX, June...

NEXALIN
13 ביוני 2024זמן קריאה 2 דקות
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
HOUSTON, TEXAS, June 5, 2024 – Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be...

NEXALIN
5 ביוני 2024זמן קריאה 1 דקות
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) ( Nasdaq: NXL; NXLIW ) announced...

NEXALIN
4 ביוני 2024זמן קריאה 3 דקות
bottom of page